ZIG
VRTX icon

Zullo Investment Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Zullo Investment Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$295K Buy
661
+2
+0.3% +$933 0.11% 124
2025
Q4 		$299K Sell
659
-20
-3% -$8.62K 0.11% 118
2025
Q3 		$266K Buy
679
+2
+0.3% +$836 0.1% 131
2025
Q2 		$301K Sell
677
-126
-16% -$58.1K 0.12% 122
2025
Q1 		$389K Buy
803
+1
+0.1% +$466 0.17% 100
2024
Q4 		$323K Buy
802
+50
+7% +$23.2K 0.13% 113
2024
Q3 		$350K Sell
752
-28
-4% -$13.4K 0.15% 107
2024
Q2 		$366K Sell
780
-14
-2% -$6.08K 0.16% 105
2024
Q1 		$332K Buy
794
+10
+1% +$4.23K 0.16% 109
2023
Q4 		$319K Buy
784
+1
+0.1% +$369 0.16% 110
2023
Q3 		$272K Hold
783
– – 0.16% 112
2023
Q2 		$276K Hold
783
– – 0.16% 113
2023
Q1 		$247K Sell
783
-35
-4% -$10.5K 0.15% 117
2022
Q4 		$236K Sell
818
-53
-6% -$16.2K 0.14% 117
2022
Q3 		$252K Sell
871
-66
-7% -$19K 0.16% 110
2022
Q2 		$264K Sell
937
-13
-1% -$3.48K 0.17% 110
2022
Q1 		$248K Sell
950
-27
-3% -$6.41K 0.13% 133
2021
Q4 		$215K Buy
+977
New +$190K 0.11% 154

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Zullo Investment Group's VRTX Position: Q1 2026 in Review

Zullo Investment Group increased its Vertex Pharmaceuticals (VRTX) stake by 0.3% in Q1 2026, buying an estimated $933 and bringing the position to 661 shares worth $295K. The position accounts for 0.11% of the portfolio, ranked #124.

Zullo Investment Group first reported a position in VRTX in Q4 2021 and has held it in 18 quarters since. The position peaked at $389K in Q1 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Zullo Investment Group held 661 shares of Vertex Pharmaceuticals worth $295K as of Q1 2026.
  • Zullo Investment Group bought 2 Vertex Pharmaceuticals shares in Q1 2026, an estimated $933.
  • Vertex Pharmaceuticals made up 0.11% of Zullo Investment Group's portfolio in Q1 2026, its #124 holding.
  • Zullo Investment Group first reported a position in Vertex Pharmaceuticals in Q4 2021 and has held it in 18 quarters since.
  • Zullo Investment Group's Vertex Pharmaceuticals position peaked at $389K in Q1 2025.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Zullo Investment Group's 13F filing for Q1 2026, filed 15 Apr 2026.